title: Evaluation and Referral for Developmental Dysplasia of the Hip in Infants.
abstract: Developmental dysplasia of the hip (DDH) encompasses a wide spectrum of clinical severity, from mild developmental abnormalities to frank dislocation. Clinical hip instability occurs in 1% to 2% of full-term infants, and up to 15% have hip instability or hip immaturity detectable by imaging studies. Hip dysplasia is the most common cause of hip arthritis in women younger than 40 years and accounts for 5% to 10% of all total hip replacements in the United States. Newborn and periodic screening have been practiced for decades, because DDH is clinically silent during the first year of life, can be treated more effectively if detected early, and can have severe consequences if left untreated. However, screening programs and techniques are not uniform, and there is little evidence-based literature to support current practice, leading to controversy. Recent literature shows that many mild forms of DDH resolve without treatment, and there is a lack of agreement on ultrasonographic diagnostic criteria for DDH as a disease versus developmental variations. The American Academy of Pediatrics has not published any policy statements on DDH since its 2000 clinical practice guideline and accompanying technical report. Developments since then include a controversial US Preventive Services Task Force "inconclusive" determination regarding usefulness of DDH screening, several prospective studies supporting observation over treatment of minor ultrasonographic hip variations, and a recent evidence-based clinical practice guideline from the American Academy of Orthopaedic Surgeons on the detection and management of DDH in infants 0 to 6 months of age. The purpose of this clinical report was to provide literature-based updated direction for the clinician in screening and referral for DDH, with the primary goal of preventing and/or detecting a dislocated hip by 6 to 12 months of age in an otherwise healthy child, understanding that no screening program has eliminated late development or presentation of a dislocated hip and that the diagnosis and treatment of milder forms of hip dysplasia remain controversial.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Shaw
authors.forename: Lee S
authors.initials: LS
authors.lastname: Segal
mesh_terms: D026683:Advisory Committees; D000367:Age Factors; D002675:Child, Preschool; D000072700:Conservative Treatment / Q000592:standards / Q000639:trends; D003952:Diagnostic Imaging; D042241:Early Diagnosis; D019317:Evidence-Based Medicine; D006618:Hip Dislocation, Congenital / Q000000981:diagnostic imaging* / Q000628:therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015997:Neonatal Screening / Q000592:standards*; D019637:Orthopedic Procedures / Q000592:standards / Q000639:trends; D017410:Practice Guidelines as Topic / Q000592:standards*; D011379:Prognosis; D016059:Range of Motion, Articular / Q000502:physiology*; D020127:Recovery of Function; D012017:Referral and Consultation / Q000706:statistics & numerical data*; D018570:Risk Assessment; D012737:Sex Factors